GR3026165T3 - A method of preventing tumor metastasis. - Google Patents
A method of preventing tumor metastasis.Info
- Publication number
- GR3026165T3 GR3026165T3 GR980400340T GR980400340T GR3026165T3 GR 3026165 T3 GR3026165 T3 GR 3026165T3 GR 980400340 T GR980400340 T GR 980400340T GR 980400340 T GR980400340 T GR 980400340T GR 3026165 T3 GR3026165 T3 GR 3026165T3
- Authority
- GR
- Greece
- Prior art keywords
- met
- hgf
- antibody
- substance
- preventing tumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94606192A | 1992-09-18 | 1992-09-18 | |
PCT/US1993/008531 WO1994006909A2 (en) | 1992-09-18 | 1993-09-15 | A method of preventing tumor metastasis |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3026165T3 true GR3026165T3 (en) | 1998-05-29 |
Family
ID=25483898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR980400340T GR3026165T3 (en) | 1992-09-18 | 1998-02-18 | A method of preventing tumor metastasis. |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP0662130B1 (el) |
JP (2) | JP3553936B2 (el) |
AT (2) | ATE160585T1 (el) |
AU (1) | AU675968B2 (el) |
CA (1) | CA2144856A1 (el) |
DE (2) | DE69315440T2 (el) |
DK (1) | DK0662130T3 (el) |
ES (1) | ES2112997T3 (el) |
GR (1) | GR3026165T3 (el) |
WO (1) | WO1994006909A2 (el) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6344321B1 (en) * | 1990-06-11 | 2002-02-05 | Gilead Sciences, Inc. | Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
US6566098B1 (en) | 1990-09-14 | 2003-05-20 | The United States Of America As Represented By The Department Of Health And Human Services | DNA encoding truncated hepatocyte growth factor variants |
CA2144081C (en) * | 1992-09-16 | 2004-11-30 | Filip Roos | Protection against liver damage by hgf |
US5646036A (en) * | 1995-06-02 | 1997-07-08 | Genentech, Inc. | Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies |
US6214344B1 (en) | 1995-06-02 | 2001-04-10 | Genetech, Inc. | Hepatocyte growth factor receptor antagonists and uses thereof |
US5686292A (en) | 1995-06-02 | 1997-11-11 | Genentech, Inc. | Hepatocyte growth factor receptor antagonist antibodies and uses thereof |
US6855685B2 (en) | 1995-10-24 | 2005-02-15 | Toshikazu Nakamura | Anti-cancer agent |
JP3832674B2 (ja) * | 1995-10-24 | 2006-10-11 | 敏一 中村 | 抗癌剤 |
CA2270867A1 (en) * | 1996-11-05 | 1998-05-14 | Smithkline Beecham Corporation | Hepatocyte growth factor antagonists |
WO2000025727A2 (en) * | 1998-11-04 | 2000-05-11 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of flumethasone, fluocinolone acetonide fluoromethasone for manufacture of a medicament for the treatment of tumours |
IL131142A0 (en) * | 1999-07-28 | 2001-01-28 | Rad Ramot | Prognosis of breast cancer and other diseases |
WO2001034650A1 (en) * | 1999-11-09 | 2001-05-17 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Heatlh And Human Services | Hgf-sf monoclonal antibody combinations |
AU2001277854B2 (en) * | 2000-06-29 | 2007-03-01 | North Shore-Long Island Jewish Health System | Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
MXPA05008521A (es) * | 2003-02-13 | 2005-10-20 | Pharmacia Corp | Anticuerpos a c-met para el tratamiento de canceres. |
PL1648998T3 (pl) | 2003-07-18 | 2015-03-31 | Amgen Inc | Specyficzne czynniki wiążące czynnik wzrostu hepatocytów |
HN2004000285A (es) | 2003-08-04 | 2006-04-27 | Pfizer Prod Inc | ANTICUERPOS DIRIGIDOS A c-MET |
CN104804095A (zh) | 2004-08-05 | 2015-07-29 | 健泰科生物技术公司 | 人源化抗c-met 拮抗剂 |
TWI362940B (en) | 2005-03-31 | 2012-05-01 | Gen Hospital Corp | A use of agonist and/or antagonist of hgf/hgfr activity |
RU2403261C2 (ru) | 2005-04-15 | 2010-11-10 | Дженентек, Инк. | Варианты бета-цепи hgf |
CA2646620C (en) | 2006-03-20 | 2015-07-14 | Seikagaku Corporation | Therapeutic agent for rheumatoid arthritis |
CN101415730B (zh) | 2006-03-30 | 2013-04-10 | 诺瓦提斯公司 | c-Met抗体的组合物和使用方法 |
EP2545077B1 (en) | 2010-03-10 | 2018-10-31 | Genmab A/S | Monoclonal antibodies against c-met |
AU2011325097B2 (en) | 2010-11-03 | 2015-05-21 | Argenx Bvba | Anti c-Met antibodies |
CA2832113C (en) * | 2011-04-02 | 2020-07-21 | Washington State University Research Foundation | Hepatocyte growth factor mimics as therapeutic agents |
CA2835242A1 (en) | 2011-06-30 | 2013-01-03 | Genentech, Inc. | Anti-c-met antibody formulations |
US9926364B2 (en) | 2011-11-03 | 2018-03-27 | Argen-X N.V. | Chimeric human-llama antigens and methods of use |
US9168300B2 (en) | 2013-03-14 | 2015-10-27 | Oncomed Pharmaceuticals, Inc. | MET-binding agents and uses thereof |
JP2017516458A (ja) | 2014-03-24 | 2017-06-22 | ジェネンテック, インコーポレイテッド | c−met拮抗剤による癌治療及びc−met拮抗剤のHGF発現との相関 |
BR112017005202A2 (pt) | 2014-09-16 | 2017-12-12 | Symphogen As | anticorpos anti-met e composições |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648273A (en) * | 1989-12-27 | 1997-07-15 | The United States Of America, As Represented By The Department Of Health And Human Services | Hepatic growth factor receptor is the MET proto-oncogene |
US5362716A (en) * | 1989-12-27 | 1994-11-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
GB9003621D0 (en) * | 1990-02-16 | 1990-04-11 | Imp Cancer Res Tech | Protein factor |
JP2784455B2 (ja) * | 1990-05-09 | 1998-08-06 | 敏一 中村 | 肝硬変治療剤 |
AU650292B2 (en) * | 1990-09-14 | 1994-06-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A non-mitogenic competitive HGF antagonist |
JPH07508420A (ja) * | 1992-05-18 | 1995-09-21 | ジェネンテク,インコーポレイテッド | 肝細胞成長因子変異体 |
-
1993
- 1993-09-15 DE DE69315440T patent/DE69315440T2/de not_active Expired - Fee Related
- 1993-09-15 DE DE69334159T patent/DE69334159D1/de not_active Expired - Lifetime
- 1993-09-15 AT AT93921471T patent/ATE160585T1/de not_active IP Right Cessation
- 1993-09-15 EP EP93921471A patent/EP0662130B1/en not_active Expired - Lifetime
- 1993-09-15 AU AU48555/93A patent/AU675968B2/en not_active Ceased
- 1993-09-15 CA CA002144856A patent/CA2144856A1/en not_active Abandoned
- 1993-09-15 DK DK93921471T patent/DK0662130T3/da active
- 1993-09-15 AT AT97201105T patent/ATE368738T1/de not_active IP Right Cessation
- 1993-09-15 EP EP97201105A patent/EP0805203B1/en not_active Expired - Lifetime
- 1993-09-15 ES ES93921471T patent/ES2112997T3/es not_active Expired - Lifetime
- 1993-09-15 JP JP50817794A patent/JP3553936B2/ja not_active Expired - Fee Related
- 1993-09-15 WO PCT/US1993/008531 patent/WO1994006909A2/en active IP Right Grant
-
1998
- 1998-02-18 GR GR980400340T patent/GR3026165T3/el unknown
-
2003
- 2003-06-10 JP JP2003165273A patent/JP2004002440A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP3553936B2 (ja) | 2004-08-11 |
ES2112997T3 (es) | 1998-04-16 |
AU4855593A (en) | 1994-04-12 |
WO1994006909A2 (en) | 1994-03-31 |
EP0805203B1 (en) | 2007-08-01 |
DE69315440T2 (de) | 1998-07-09 |
JP2004002440A (ja) | 2004-01-08 |
EP0662130A1 (en) | 1995-07-12 |
JPH08504093A (ja) | 1996-05-07 |
DE69315440D1 (de) | 1998-01-08 |
DE69334159D1 (de) | 2007-09-13 |
ATE368738T1 (de) | 2007-08-15 |
DK0662130T3 (da) | 1998-08-10 |
ATE160585T1 (de) | 1997-12-15 |
CA2144856A1 (en) | 1994-03-31 |
EP0805203A1 (en) | 1997-11-05 |
AU675968B2 (en) | 1997-02-27 |
WO1994006909A3 (en) | 1994-05-26 |
EP0662130B1 (en) | 1997-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3026165T3 (en) | A method of preventing tumor metastasis. | |
NO2017038I1 (no) | Adalimumab - Forlenget SPC | |
EP0724456A4 (en) | ANTIBODIES AGAINST CD40 | |
MY145191A (en) | Human antibodies that bind human il-12 and methods for producing | |
MX9702700A (es) | El uso de compuestos heterociclicos para el tratamiento de tumores resistentes. | |
HK1052871A1 (zh) | 新城疫病毒的治療用途 | |
HK1016018A1 (en) | Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin | |
HK1086283A1 (en) | Antibodies that bind cell-associated ca 125/0722p and methods of use thereof | |
PL328858A1 (en) | Immunogenous peptides | |
ATE162079T1 (de) | Verwendung von antikörper enthaltenden präparationen zur immunsuppression | |
DE3482905D1 (de) | Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs. | |
DE69328928D1 (de) | Varianten in den leltin domäne von selektin | |
GB9009106D0 (en) | Processes and intermediates for synthetic antibody derivatives | |
IE821855L (en) | Glycerophosphocholines | |
FI922551A0 (fi) | Foerfarande foer skoetsel av septisk chock. | |
ATE222927T1 (de) | Monoklonaler antikörper gegen den tumorzytotoxischen faktor ii (tcf-ii) | |
AT388689B (de) | Schiebeverschluss fuer den ausguss metallurgischer gefaesse | |
EP0651816A4 (en) | LEVELS OF CCK PEPTIDES IN BLOOD IN RELATION TO THE TREATMENT OF PANIC EARTHS. | |
Gurjevitch | Rasryschitelnoe b tscheloveke kak tajny | |
IL97629A0 (en) | Bcrf1 antagonists for treating epstein-barr virus infections | |
Durand-Charre et al. | Structure and Solidification Sequence of Alloyed White Cast Irons.(Synopsis) | |
JPS5572153A (en) | Undecapeptide | |
ES267893Y (es) | "contenedor-conservador de vinos embotellados". | |
NO822140L (no) | Stengeanordning for lukedeksler. |